Some patients may experience nausea, headache, or a feeling of sleepiness after the injection
These drugs mimic the effects of a hormone called GLP-1, which is produced in the intestines in response to food intake
Anabolic signaling dynamic investigation in controlled preclinical research systems
Wong HJ, Sim B, Teo YH, Teo YN, Chan MY, Yeo LLL, et al
This observation ultimately led to the approval of higher-dose formulations of liraglutide (Saxenda) and semaglutide (Wegovy) specifically for sustained weight management, formally repositioning GLP-1 medications as obesity treatments rather than solely diabetes medications
Caring for Your Family Since 1999 Disclaimer: The medical information on this site is provided as an information resource only and is not to be used or relied on for any diagnostic or treatment purposes